(1)要約四半期連結純損益計算書

(単位:百万円)

 

 

前第3四半期連結累計期間

(自 2024年4月1日

至 2024年12月31日)

 

当第3四半期連結累計期間

(自 2025年4月1日

至 2025年12月31日)

売上収益

 

1,453,029

 

1,601,320

売上原価

 

272,348

 

314,759

売上総利益

 

1,180,681

 

1,286,561

 

 

 

 

 

販売費及び一般管理費

 

631,716

 

625,613

研究開発費

 

251,422

 

218,884

無形資産償却費

 

104,201

 

100,218

無形資産譲渡益

 

993

 

4,016

持分法による投資損益

 

621

 

1,627

その他の収益

 

4,417

 

25,417

その他の費用

 

220,613

 

35,770

営業利益(△は損失)

 

22,481

 

333,880

 

 

 

 

 

金融収益

 

6,934

 

5,720

金融費用

 

13,770

 

11,037

税引前四半期利益(△は損失)

 

29,317

 

328,563

法人所得税費用

 

5,168

 

80,605

四半期利益(△は損失)

 

24,149

 

247,958

 

 

 

 

 

四半期利益(△は損失)の帰属

 

 

 

 

親会社の所有者

 

24,149

 

248,014

非支配持分

 

 

55

四半期利益(△は損失)

 

24,149

 

247,958

 

 

 

 

 

1株当たり四半期利益

 

 

 

 

基本的1株当たり四半期利益(△は損失)(円)

 

13.49

 

138.48

希薄化後1株当たり四半期利益(△は損失)(円)

 

13.49

 

138.02

 

E00920 45030 アステラス製薬株式会社 Astellas Pharma Inc. 四半期第3号参考様式 [IFRS](連結) IFRS true cte 2025-04-01 2025-12-31 Q3 2026-03-31 2024-04-01 2024-12-31 2025-03-31 1 false false false 45030 2026-02-04 45030 2025-12-31 45030 2025-12-31 jpigp_cor:CapitalSurplusIFRSMember 45030 2025-12-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2025-12-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2025-12-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2025-12-31 jpigp_cor:NonControllingInterestsIFRSMember 45030 2025-12-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2025-12-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2025-12-31 jpigp_cor:RetainedEarningsIFRSMember 45030 2025-12-31 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2025-12-31 jpigp_cor:ShareCapitalIFRSMember 45030 2025-12-31 jpigp_cor:TreasurySharesIFRSMember 45030 2025-04-01 2025-12-31 45030 2025-04-01 2025-12-31 jpigp_cor:CapitalSurplusIFRSMember 45030 2025-04-01 2025-12-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2025-04-01 2025-12-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2025-04-01 2025-12-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2025-04-01 2025-12-31 jpigp_cor:NonControllingInterestsIFRSMember 45030 2025-04-01 2025-12-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2025-04-01 2025-12-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2025-04-01 2025-12-31 jpigp_cor:RetainedEarningsIFRSMember 45030 2025-04-01 2025-12-31 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2025-04-01 2025-12-31 jpigp_cor:ShareCapitalIFRSMember 45030 2025-04-01 2025-12-31 jpigp_cor:TreasurySharesIFRSMember 45030 2024-12-31 45030 2024-12-31 jpigp_cor:CapitalSurplusIFRSMember 45030 2024-12-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2024-12-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2024-12-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2024-12-31 jpigp_cor:NonControllingInterestsIFRSMember 45030 2024-12-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2024-12-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2024-12-31 jpigp_cor:RetainedEarningsIFRSMember 45030 2024-12-31 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2024-12-31 jpigp_cor:ShareCapitalIFRSMember 45030 2024-12-31 jpigp_cor:TreasurySharesIFRSMember 45030 2025-03-31 45030 2025-03-31 jpigp_cor:CapitalSurplusIFRSMember 45030 2025-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2025-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2025-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2025-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45030 2025-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2025-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2025-03-31 jpigp_cor:RetainedEarningsIFRSMember 45030 2025-03-31 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2025-03-31 jpigp_cor:ShareCapitalIFRSMember 45030 2025-03-31 jpigp_cor:TreasurySharesIFRSMember 45030 2024-04-01 2024-12-31 45030 2024-04-01 2024-12-31 jpigp_cor:CapitalSurplusIFRSMember 45030 2024-04-01 2024-12-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2024-04-01 2024-12-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2024-04-01 2024-12-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2024-04-01 2024-12-31 jpigp_cor:NonControllingInterestsIFRSMember 45030 2024-04-01 2024-12-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2024-04-01 2024-12-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2024-04-01 2024-12-31 jpigp_cor:RetainedEarningsIFRSMember 45030 2024-04-01 2024-12-31 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2024-04-01 2024-12-31 jpigp_cor:ShareCapitalIFRSMember 45030 2024-04-01 2024-12-31 jpigp_cor:TreasurySharesIFRSMember 45030 2024-03-31 45030 2024-03-31 jpigp_cor:CapitalSurplusIFRSMember 45030 2024-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2024-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2024-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2024-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45030 2024-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2024-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2024-03-31 jpigp_cor:RetainedEarningsIFRSMember 45030 2024-03-31 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2024-03-31 jpigp_cor:ShareCapitalIFRSMember 45030 2024-03-31 jpigp_cor:TreasurySharesIFRSMember iso4217:JPY iso4217:JPY xbrli:shares xbrli:pure